In theory, restoring miR-532 levels in cancer would suppress oncogenic E2F1 expression, which in turn would weaken the inhibition of miR-532, thereby promoting the accumulation of miR-532 in cancer cells and delaying tumor growth. The gene discussed is E2F1; the disease is neoplasm.